US Patent Issued to Chugai Seiyaku on Jan. 20 for "Method for predicting sensitivity of cancer cell to GPX4 inhibitor" (Japanese Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,701, issued on Jan. 20, was assigned to Chugai Seiyaku K.K. (Tokyo).

"Method for predicting sensitivity of cancer cell to GPX4 inhibitor" was invented by Kiyomoto Ogasawara (Kanagawa, Japan), Keisuke Hashimoto (Kanagawa, Japan), Kenji Kashima (Kanagawa, Japan) and Hiroshi Sakamoto (Kanagawa, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a cancer therapeutic drug comprising a compound which inhibits GPX4 as an active ingredient, the cancer therapeutic drug treating cancer containing a cancer cell having a suppressed function of a SWI/SNF complex factor detected; and a method for predicting sensitivity of a cancer cell to a GPX4 in...